alexa Profiling Physiochemical Properties Of Drug-eluting Bead Emulsions: In Vitro Design Evaluation And Clinical Application | 41633
ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Share This Page

Profiling physiochemical properties of drug-eluting bead emulsions: In vitro design evaluation and clinical application

Annual Conference and Expo on Biomaterials

Marcus Caine, Chung T1, Tang Y, Zhang X, Hill M, Willis S L, Dreher M R and Lewis A L

Biocompatibles UK Ltd, UK University of Southampton, UK

ScientificTracks Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.C1.049

The primary purpose of Trans-Arterial Chemoembolization (TACE) is to restrict blood supply to hyper vascularized tumors whilst delivering a chemotherapeutic drug in a localized, consistent and efficacious regimen. Clinical opinion is divided regarding the primary mode of action. Physical embolic or controlled drug release. Both the use of ethiodized oil emulsions mixed with doxorubicin (conventional cTACE) and ionically loaded Drug-Eluting Beads (DEB-TACE) provide proven clinical efficacy. Recent developments in emulsion stabilization have posed the question of whether the safety of reduced systemic drug exposure provided by DEB could be combined with oil emulsions to provide a therapeutic benefit in patients. In a study conducted by Takayasu et al., n=11030 patients treated with oil emulsions vs emulsions and particulates presented an overall survival benefit in the particulate combination therapy. This study evaluates novel radiopaque DEB in combination with oil emulsions using in vitro-in vivo flow distribution, drug release profiles and physiochemical stability. Bead stabilized emulsions were easily prepared and doxorubicin loading into the DEB was rapid. In vitro DEB emulsions exhibited enhanced physical embolic abilities with slower drug elution kinetics vs c-TACE. In vivo VX2 tumor model confirmed low systemic doxorubicin, anti-tumor activity and CT imaging at 7 days clearly showed oil droplets remaining throughout the liver lobe and targeted arteries filled with radiopaque beads. Fluoroscopy in a porcine hepatic arterial and in vitro vascular flow model indicated comparable flow characteristics during administration to that of c-TACE.

Marcus Caine is an Innovation Scientist at BTG. Initially focusing on analytical method development and validation, he is pursuing part-time PhD with the University of Southampton in Applied Biomimetic Microfluidics and focusing on the application of the project for advancing treatment in the field of interventional oncology and pulmonology.

Email: [email protected]